• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯胺酮使用 50 年:从麻醉到快速抗抑郁作用和神经生物学机制。

Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.

机构信息

Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, P. O. Box 56, 00014, Helsinki, Finland.

SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20.

DOI:10.1007/s43440-021-00232-4
PMID:33609274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7994242/
Abstract

Over the past 50 years, ketamine has solidified its position in both human and veterinary medicine as an important anesthetic with many uses. More recently, ketamine has been studied and used for several new indications, ranging from chronic pain to drug addiction and post-traumatic stress disorder. The discovery of the rapid-acting antidepressant effects of ketamine has resulted in a surge of interest towards understanding the precise mechanisms driving its effects. Indeed, ketamine may have had the largest impact for advancements in the research and treatment of psychiatric disorders in the past few decades. While intense research efforts have been aimed towards uncovering the molecular targets underlying ketamine's effects in treating depression, the underlying neurobiological mechanisms remain elusive. These efforts are made more difficult by ketamine's complex dose-dependent effects on molecular mechanisms, multiple pharmacologically active metabolites, and a mechanism of action associated with the facilitation of synaptic plasticity. This review aims to provide a brief overview of the different uses of ketamine, with an emphasis on examining ketamine's rapid antidepressant effects spanning molecular, cellular, and network levels. Another focus of the review is to offer a perspective on studies related to the different doses of ketamine used in antidepressant research. Finally, the review discusses some of the latest hypotheses concerning ketamine's action.

摘要

在过去的 50 年中,氯胺酮在人类和兽医医学中都确立了其作为一种具有多种用途的重要麻醉剂的地位。最近,氯胺酮已被研究并用于多种新的适应症,从慢性疼痛到药物成瘾和创伤后应激障碍。氯胺酮具有快速抗抑郁作用的发现导致人们对理解其作用的确切机制产生了浓厚的兴趣。事实上,在过去几十年中,氯胺酮可能对精神疾病的研究和治疗进展产生了最大的影响。尽管人们一直在努力研究揭示氯胺酮治疗抑郁症作用的分子靶点,但潜在的神经生物学机制仍然难以捉摸。氯胺酮对分子机制、多种具有药理活性的代谢物以及与促进突触可塑性相关的作用机制的复杂剂量依赖性影响,使这些努力变得更加困难。本综述旨在简要概述氯胺酮的不同用途,并重点研究氯胺酮在分子、细胞和网络水平上的快速抗抑郁作用。本综述的另一个重点是提供有关抗抑郁研究中使用的不同剂量的氯胺酮的相关研究的观点。最后,该综述讨论了一些关于氯胺酮作用的最新假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/6698d2114b5e/43440_2021_232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/57fecbadc752/43440_2021_232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/a8a7f9efd857/43440_2021_232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/188da8d1e0a5/43440_2021_232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/6698d2114b5e/43440_2021_232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/57fecbadc752/43440_2021_232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/a8a7f9efd857/43440_2021_232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/188da8d1e0a5/43440_2021_232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8451/7994242/6698d2114b5e/43440_2021_232_Fig4_HTML.jpg

相似文献

1
Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.氯胺酮使用 50 年:从麻醉到快速抗抑郁作用和神经生物学机制。
Pharmacol Rep. 2021 Apr;73(2):323-345. doi: 10.1007/s43440-021-00232-4. Epub 2021 Feb 20.
2
Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.氯胺酮的剂量相关多重作用机制:分离麻醉剂到快速抗抑郁药。
Behav Brain Res. 2020 Jul 15;390:112631. doi: 10.1016/j.bbr.2020.112631. Epub 2020 May 8.
3
Mechanisms of ketamine action as an antidepressant.氯胺酮作为抗抑郁药的作用机制。
Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13.
4
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.氯胺酮快速起效的抗抑郁作用机制是什么?对大量惊人可能性的简要概述。
J Clin Pharm Ther. 2017 Apr;42(2):147-154. doi: 10.1111/jcpt.12497. Epub 2017 Jan 22.
5
Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.增加氯胺酮剂量会抑制抗抑郁反应并抑制相关的突触信号通路。
Behav Brain Res. 2020 Feb 17;380:112378. doi: 10.1016/j.bbr.2019.112378. Epub 2019 Nov 21.
6
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.氯胺酮的作用机制:通往速效抗抑郁药之路。
Depress Anxiety. 2016 Aug;33(8):689-97. doi: 10.1002/da.22501. Epub 2016 Apr 6.
7
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.氯胺酮滥用及其作为抗抑郁药使用背后的神经回路和分子机制存在重叠。
Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13.
8
Ketamine's rapid and sustained antidepressant effects are driven by distinct mechanisms.氯胺酮的快速和持续抗抑郁作用是由不同的机制驱动的。
Cell Mol Life Sci. 2024 Feb 27;81(1):105. doi: 10.1007/s00018-024-05121-6.
9
Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.快速作用抗抑郁药氯胺酮对小鼠大脑的时间神经分子和突触发生效应的性别差异。
Neuroscience. 2019 Feb 1;398:182-192. doi: 10.1016/j.neuroscience.2018.11.053. Epub 2018 Dec 8.
10
Ketamine: The final frontier or another depressing end?氯胺酮:是最终的前沿领域还是又一个令人沮丧的结局?
Behav Brain Res. 2020 Apr 6;383:112508. doi: 10.1016/j.bbr.2020.112508. Epub 2020 Feb 1.

引用本文的文献

1
Ketamine Reverses Chronic Stress-Induced Behavioral Changes via the Expression of Ca-Permeable AMPA Receptors in Mice.氯胺酮通过小鼠中钙通透性AMPA受体的表达逆转慢性应激诱导的行为变化。
FASEB J. 2025 Aug 31;39(16):e70891. doi: 10.1096/fj.202501763R.
2
Ketamine's impact on mood after day-case surgery and its relation to obesity: a randomised controlled trial in women undergoing fractional curettage.氯胺酮对日间手术术后情绪的影响及其与肥胖的关系:一项针对接受分段刮宫术女性的随机对照试验
BMC Womens Health. 2025 Jul 30;25(1):380. doi: 10.1186/s12905-025-03920-y.
3
Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression.

本文引用的文献

1
A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants.警醒:快速抗抑郁药研究中的睡眠生理学和相关转化差异。
Prog Neurobiol. 2021 Nov;206:102140. doi: 10.1016/j.pneurobio.2021.102140. Epub 2021 Aug 14.
2
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.一项重复使用氯胺酮治疗慢性创伤后应激障碍的随机对照试验。
Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5.
3
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.
艾司氯胺酮优化了右美托咪定治疗合并抑郁症的睡眠障碍的疗效。
Neuropsychiatr Dis Treat. 2025 Jul 12;21:1409-1423. doi: 10.2147/NDT.S530265. eCollection 2025.
4
Effects of Remimazolam Tosilate Combined with Esketamine on Anesthetic Efficacy and Psychiatric Symptoms in Patients Undergoing Ambulatory Surgery: A Randomized Controlled Study.甲苯磺酸瑞马唑仑联合艾司氯胺酮对门诊手术患者麻醉效果及精神症状的影响:一项随机对照研究
Drug Des Devel Ther. 2025 May 30;19:4527-4535. doi: 10.2147/DDDT.S519732. eCollection 2025.
5
Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review.氯胺酮使用的安全性考量与风险缓解策略:一项全面综述
Ann Med Surg (Lond). 2025 Apr 2;87(5):2829-2837. doi: 10.1097/MS9.0000000000003232. eCollection 2025 May.
6
Effective doses of remimazolam and esketamine combined with remifentanil for endotracheal intubation without muscle relaxants in pediatric patients.瑞米唑仑与艾司氯胺酮联合瑞芬太尼用于小儿患者无肌松剂气管插管的有效剂量。
Front Pharmacol. 2025 Mar 18;16:1558966. doi: 10.3389/fphar.2025.1558966. eCollection 2025.
7
Trends in poisonings involving ketamine in the United States, 2019-2023.2019 - 2023年美国氯胺酮中毒趋势
Drug Alcohol Depend. 2025 Mar 1;268:112549. doi: 10.1016/j.drugalcdep.2025.112549. Epub 2025 Jan 11.
8
Beyond NMDA Receptors: A Narrative Review of Ketamine's Rapid and Multifaceted Mechanisms in Depression Treatment.超越NMDA受体:氯胺酮治疗抑郁症的快速及多方面机制的叙述性综述
Int J Mol Sci. 2024 Dec 20;25(24):13658. doi: 10.3390/ijms252413658.
9
Diversion of Undistributed Pharmaceutical Ketamine in the US.美国未分配的药用氯胺酮的转移
JAMA. 2025 Jan 21;333(3):252-254. doi: 10.1001/jama.2024.23014.
10
Characterization of the temporal profile of the antinociceptive effects of an intravenous bolus of ketamine using the analgesia nociception index in no-anesthetized adult patients.在未麻醉的成年患者中,使用镇痛伤害感受指数对静脉推注氯胺酮的镇痛作用的时间特征进行表征。
J Clin Monit Comput. 2025 Apr;39(2):349-354. doi: 10.1007/s10877-024-01240-4. Epub 2024 Nov 15.
氯胺酮引起的神秘体验介导了其对高危饮酒的影响:一项随机对照试验的结果。
J Psychopharmacol. 2021 Feb;35(2):150-158. doi: 10.1177/0269881120970879. Epub 2020 Dec 13.
4
Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine.时间至关重要:将睡眠-觉醒与昼夜节律神经生物学与氯胺酮的抗抑郁作用相联系。
Pharmacol Ther. 2021 May;221:107741. doi: 10.1016/j.pharmthera.2020.107741. Epub 2020 Nov 12.
5
Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study.氯胺酮辅助行为治疗大麻使用障碍:概念验证研究。
Am J Drug Alcohol Abuse. 2021 Jan 2;47(1):92-97. doi: 10.1080/00952990.2020.1808982. Epub 2020 Nov 11.
6
Can 'floating' predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression.“漂浮”能否预测氯胺酮治疗的反应?来自三项针对治疗抵抗性抑郁症个体的随机试验的数据。
J Psychiatr Res. 2020 Nov;130:280-285. doi: 10.1016/j.jpsychires.2020.06.012. Epub 2020 Jul 30.
7
The emergence of ketamine as a novel treatment for posttraumatic stress disorder.氯胺酮作为创伤后应激障碍新型治疗方法的出现。
Adv Pharmacol. 2020;89:261-286. doi: 10.1016/bs.apha.2020.05.004. Epub 2020 Jun 19.
8
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression.一项关于重复使用与单次亚麻醉剂量氯胺酮治疗难治性抑郁症的疗效、安全性和持久性的随机、双盲、活性安慰剂对照研究。
Transl Psychiatry. 2020 Jun 26;10(1):206. doi: 10.1038/s41398-020-00897-0.
9
Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice.氯胺酮可阻断小鼠中吗啡诱导的条件性位置偏爱和类焦虑行为。
Front Behav Neurosci. 2020 May 21;14:75. doi: 10.3389/fnbeh.2020.00075. eCollection 2020.
10
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.在一项针对难治性重度抑郁症的随机、安慰剂对照、交叉试验中,氯胺酮代谢物、临床反应和γ波功率
Neuropsychopharmacology. 2020 Jul;45(8):1398-1404. doi: 10.1038/s41386-020-0663-6. Epub 2020 Apr 6.